The objective of this systematic review was to evaluate the efficacy of immunosuppressive therapy in patients with connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) and to further assess whether response differs between CTD subtypes and clinical features. To read the full article, choose “Institutional Login” and search for “Midlands Partnership”.